Literature DB >> 27904702

Ethanol extracts from Portulaca oleracea L. attenuated ischemia/reperfusion induced rat neural injury through inhibition of HMGB1 induced inflammation.

Chenggang Zheng1, Chen Liu2, Wanyin Wang1, Gusheng Tang3, Liwei Dong2, Juan Zhou4, Zhengrong Zhong5.   

Abstract

It is well demonstrated that the high mobility group box 1 (HMGB1) mediated inflammation has been implicated as one of the important causes for brain damage induced by cerebral ischemia/reperfusion (I/R). In the present study, we assessed the neuro-protective and anti-inflammation effects of the ethanol extracts from Portulaca oleracea L. (EEPO) against cerebral I/R injury in the rat transient middle cerebral artery occlusion (tMCAO) model. Rats were administrated with their respective treatment for 7 days before the MCA occlusion. After that, rats were intraperitoneal injection with chloral hydrate and sacrificed by decapitation, then the serum and brain tissue were collected. The neurological deficit score, infarct size and brain edema were tested. The levels of serum cytokine as TNF-α, IL-1β, INF-γ, IL-6, and HMGB1 and LDH were detected. The protein level of tissue or nucleus HMGB1, IκB and p-p65 were tested, too. The results showed that pretreatment with EEPO significantly decreased the neurological deficit score, infarct size and brain edema. Moreover, EEPO decreased rat serum cytokine level and rat right cortices p-p65 and IκB protein level. In conclusion all these results suggested that pretreatment with EEFPO provided significant protection against cerebral I/R injury in rats might by virtue of its anti-inflammation property through inhibition of increase of neuleus HMGB1.

Entities:  

Keywords:  Portulaca oleracea L; brain; high mobility group box 1; ischemia/reperfusion

Year:  2016        PMID: 27904702      PMCID: PMC5126344     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  33 in total

Review 1.  HMGB1 as a late mediator of lethal systemic inflammation.

Authors:  H Wang; H Yang; C J Czura; A E Sama; K J Tracey
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

Review 2.  The harms and benefits of inflammatory and immune responses in vascular disease.

Authors:  Angel Chamorro; John Hallenbeck
Journal:  Stroke       Date:  2006-01-12       Impact factor: 7.914

3.  Bilobalide prevents ischemia-induced edema formation in vitro and in vivo.

Authors:  A Mdzinarishvili; C Kiewert; V Kumar; M Hillert; J Klein
Journal:  Neuroscience       Date:  2006-10-02       Impact factor: 3.590

4.  The high-mobility group box-1 nuclear factor mediates retinal injury after ischemia reperfusion.

Authors:  Galina Dvoriantchikova; Eleut Hernandez; Jeff Grant; Andrea Rachelle C Santos; Huan Yang; Dmitry Ivanov
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-09       Impact factor: 4.799

5.  Ethanol extract of Portulaca oleracea L. protects against hypoxia-induced neuro damage through modulating endogenous erythropoietin expression.

Authors:  Wang Wanyin; Dong Liwei; Jia Lin; Xin Hailiang; Ling Changquan; Li Min
Journal:  J Nutr Biochem       Date:  2011-05-02       Impact factor: 6.048

Review 6.  Combating innate inflammation: a new paradigm for acute treatment of stroke?

Authors:  Guido Stoll; Christoph Kleinschnitz; Bernhard Nieswandt
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

7.  High mobility group 1 B-box mediates activation of human endothelium.

Authors:  C J Treutiger; G E Mullins; A-S M Johansson; A Rouhiainen; H M E Rauvala; H Erlandsson-Harris; U Andersson; H Yang; K J Tracey; J Andersson; J E W Palmblad
Journal:  J Intern Med       Date:  2003-10       Impact factor: 8.989

8.  Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1.

Authors:  A N Rashed; F U Afifi; A M Disi
Journal:  J Ethnopharmacol       Date:  2003-10       Impact factor: 4.360

Review 9.  High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity.

Authors:  Marco E Bianchi; Angelo A Manfredi
Journal:  Immunol Rev       Date:  2007-12       Impact factor: 12.988

10.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

View more
  4 in total

1.  Inhibition of HMGB1 reduces rat spinal cord astrocytic swelling and AQP4 expression after oxygen-glucose deprivation and reoxygenation via TLR4 and NF-κB signaling in an IL-6-dependent manner.

Authors:  Lin Sun; Man Li; Xun Ma; Haoyu Feng; Junlai Song; Cong Lv; Yajun He
Journal:  J Neuroinflammation       Date:  2017-11-25       Impact factor: 8.322

2.  Ginsenoside Rb1 administration attenuates focal cerebral ischemic reperfusion injury through inhibition of HMGB1 and inflammation signals.

Authors:  Anxin Liu; Weiwei Zhu; Lirui Sun; Guangming Han; Huiping Liu; Zhaoyu Chen; Li Zhuang; Wen Jiang; Xia Xue
Journal:  Exp Ther Med       Date:  2018-07-26       Impact factor: 2.447

3.  Elevated microRNA-129-5p level ameliorates neuroinflammation and blood-spinal cord barrier damage after ischemia-reperfusion by inhibiting HMGB1 and the TLR3-cytokine pathway.

Authors:  Xiao-Qian Li; Feng-Shou Chen; Wen-Fei Tan; Bo Fang; Zai-Li Zhang; Hong Ma
Journal:  J Neuroinflammation       Date:  2017-10-23       Impact factor: 8.322

4.  Salvianolic Acid D Alleviates Cerebral Ischemia-Reperfusion Injury by Suppressing the Cytoplasmic Translocation and Release of HMGB1-Triggered NF-κB Activation to Inhibit Inflammatory Response.

Authors:  Wen Zhang; Junke Song; Wan Li; Dewen Kong; Yu Liang; Xiaoyue Zhao; Guanhua Du
Journal:  Mediators Inflamm       Date:  2020-01-22       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.